-
effectivehealthcare.ahrq.gov/sites/default/files/epc-disclosure-policy-form.pdf
March 01, 2023 - Disclosure Policy and Form
AHRQ Evidence-based Practice Center Policy on Financial and Nonfinancial
Interests
Background and Purpose of Policy
To maintain public confidence in the scientific integrity and credibility of work produced by the EPC
Program, it is essential that all aspects of the process and metho…
-
www.ahrq.gov/sites/default/files/wysiwyg/sops/surveys/asc/asc-resource-list.pdf
April 01, 2023 - Resource List - AHRQ Ambulatory Surgery Center Survey
SOPS Ambulatory Surgery Center Survey Resource List 1
Improving Patient Safety in Ambulatory Surgery
Centers: A Resource List for Users of the AHRQ
Ambulatory Surgery Center Survey on Patient Safety
Culture
I. Purpose
This document provides a list of ref…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-tests-metaanalysis_methods.pdf
July 01, 2012 - Methods Guide for Medical Test Reviews
8-1
Chapter 8
Meta-Analysis of Test Performance
When There Is a “Gold Standard”
Thomas A. Trikalinos, M.D., Tufts Evidence-based Practice Center, Boston, MA
Cynthia M. Balion, Ph.D., Hamilton General Hospital and McMaster Evidence-based
Practice Center, Hamilton, …
-
www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-safety-resources/resources/advances-in-patient-safety-2/vol3/Advances-Gururaja_7.pdf
January 24, 2008 - Examining the Effectiveness of Debriefing at the Point of Care in Simulation-Based Operating Room Team Training
Examining the Effectiveness of Debriefing at the
Point of Care in Simulation-Based Operating Room
Team Training
Ramnarayan Paragi Gururaja, MD, MPH; Tong Yang, MD, MS; John T. Paige, MD;
Sheila W. C…
-
effectivehealthcare.ahrq.gov/products/preterm-birth-terbutaline-pump/research-protocol
-
effectivehealthcare.ahrq.gov/products/gestational-diabetes-screening-diagnosis/research-protocol
-
effectivehealthcare.ahrq.gov/products/alcohol-misuse/research-protocol
-
digital.ahrq.gov/sites/default/files/docs/resource/davidson.pdf
June 16, 2021 - warehouse infrastructure supporting CACHIE QIS
solution within the scope of the AHRQ Deliverable as defined … EMR and EPM system instances
Create a consolidated, integrated Data warehouse referencing CACHIE defined … Vocabulary (ICD9-CM, CPT4, LOINC, and HL V2.6 Code sets where
applicable)
Deliver a set of CACHIE defined … All patients in the DM
Registry as of reporting date
See DM005
Note: Retinal exam defined as
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/insulin-blood-sugar-2010_disposition-comments.pdf
January 01, 2010 - Reviewer 5 General 1 definitely clinically meaningful
2 Target audience not very clearly defined
3 … Both target
population and audience are explicitly
defined. … exclusion criteria are
reasonable, the search strategies logical,
and the outcome measures clearly defined
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/ace-inhibitor-arb-update-surveillance-160328.pdf
May 29, 2025 - $Bookmark$not$defined." … medication$discontinuation$rates$were$higher$in$
ACEI"treated$patients$and$by$RCTs$with$very$loosely$defined … medication$
discontinuation$rates$were$
higher$in$ACEI"treated$patients$
and$by$RCTs$with$very$loosely$
defined
-
www.ahrq.gov/sites/default/files/wysiwyg/chsp/compendium/2018-chsp-tin-linkage-file-tech-doc.pdf
January 01, 2018 - Physician-to-system affiliations are defined as
attending (for system hospitals) and IDN affiliated. … addition, the OneKey data include assignments of organizational entities referred to as
medical groups (defined … In the MD-PPAS file, we defined physicians switching
TINs as those consistently billing to one TIN as
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/uM5P-6XpsqVfEC2axGnZaD
November 16, 2020 - As defined by
the US Food and Drug Administration, tobacco products include
any product made or derived … ratio [RR], 1.76 [95% CI, 1.58-1.96]).13,56 When stratified by inten-
sity level, both minimal advice (defined … as a single session lasting <20
minutes with �1 follow-up sessions) and intensive advice (defined
as
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2012_MaskedStats_Core_Weighted.PDF
January 01, 2012 - Nonspecific chest pain 460,210 1.26%
103: Pulmonary heart disease 192,280 0.53%
104: Other and ill-defined … 575,535 1.58%
110: Occlusion or stenosis of precerebral arteries 108,315 0.30%
111: Other and ill-defined … 0.12%
162: Other diseases of bladder and urethra 20,690 0.06%
163: Genitourinary symptoms and ill-defined
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2003_SummaryStats_CORE.PDF
January 01, 2003 - 102: Nonspecific chest pain 180392 2.26
103: Pulmonary heart disease 26968 0.34
104: Other and ill-defined … disease 116771 1.46
110: Occlusion or stenosis of precerebral arteries 32163 0.40
111: Other and ill-defined … 9978 0.13
162: Other disease of bladder and urethra 5916 0.07
163: Genitourinary symptoms and ill-defined
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2003_SummaryStats_10PCT_SAMPLE_A.PDF
January 01, 2003 - 102: Nonspecific chest pain 17977 2.25
103: Pulmonary heart disease 2680 0.34
104: Other and ill-defined … disease 11772 1.48
110: Occlusion or stenosis of precerebral arteries 3259 0.41
111: Other and ill-defined … 1005 0.13
162: Other disease of bladder and urethra 605 0.08
163: Genitourinary symptoms and ill-defined
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2003_SummaryStats_10PCT_SAMPLE_B.PDF
January 01, 2003 - 102: Nonspecific chest pain 18250 2.29
103: Pulmonary heart disease 2662 0.33
104: Other and ill-defined … disease 11732 1.47
110: Occlusion or stenosis of precerebral arteries 3172 0.40
111: Other and ill-defined … 1014 0.13
162: Other disease of bladder and urethra 571 0.07
163: Genitourinary symptoms and ill-defined
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/LSbrGFWSvekVzhcxwjTuXv
February 01, 2016 - cancer diagnosed during the screening
intervention period, and in some trials, within an addi-
tional defined … system based on tumor
size, lymph node involvement, and presence of metas-
tasis (71), most trials defined … cancer diagnosed during the screening intervention period, and in some trials,
within an additional defined
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2006_MaskedStats_Core_Weighted.PDF
January 01, 2006 - 102: Nonspecific chest pain 856948 2.17
103: Pulmonary heart disease 160794 0.41
104: Other and ill-defined … disease 536658 1.36
110: Occlusion or stenosis of precerebral arteries 144472 0.37
111: Other and ill-defined … 47424 0.12
162: Other disease of bladder and urethra 25201 0.06
163: Genitourinary symptoms and ill-defined
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2005_SummaryStats_CORE.PDF
January 01, 2005 - 102: Nonspecific chest pain 168756 2.11
103: Pulmonary heart disease 29571 0.37
104: Other and ill-defined … disease 107639 1.35
110: Occlusion or stenosis of precerebral arteries 28869 0.36
111: Other and ill-defined … 10204 0.13
162: Other disease of bladder and urethra 5255 0.07
163: Genitourinary symptoms and ill-defined
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2004_SummaryStats_10PCT_SAMPLE_A.PDF
January 01, 2004 - 102: Nonspecific chest pain 17534 2.19
103: Pulmonary heart disease 2788 0.35
104: Other and ill-defined … disease 11351 1.42
110: Occlusion or stenosis of precerebral arteries 2874 0.36
111: Other and ill-defined … ureters 997 0.12
162: Other disease of bladder and urethra 509 0.06
163: Genitourinary symptoms and ill-defined